Status:
TERMINATED
Study Evaluating SCA-136 Tolerability With Dose Titration and Food
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To evaluate whether the tolerability of SCA-136 is improved by dosing with food or by increasing dose amounts in a step-wise fashion.
Eligibility Criteria
Inclusion
- Healthy men or women, aged 18 to 50 years
Exclusion
- Abnormal vital signs, ECG, or lab results
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00420706
Start Date
December 1 2006
End Date
December 1 2006
Last Update
December 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States, 33126